FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.9  |  FHIR Version n/a  User: [n/a]

385224003: Powder for conventional release suspension for injection (dose form)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1459403017 Powder for injection suspension (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
1479481018 Powder for injection suspension en Synonym Inactive Entire term case insensitive SNOMED CT core module
2647451016 Powder for suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
2660098010 Powder for injection suspension (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3620910017 Powder for conventional release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620911018 Powder for conventional release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
46814601000001116 Powder and solvent for suspension for injection en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom Edition module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for conventional release suspension for injection Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Drug powder false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Powder for reconstitution for drug product false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Injection false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Injection powder false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Parenteral dose form true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form administration method Inject true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form transformation Disperse true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has basic dose form Powder true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lyophilized powder for conventional release suspension for injection Is a True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Is a False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Lyophilized powder for prolonged-release suspension for injection Is a False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Lyophilized powder for conventional release liposomal suspension for injection Is a False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Leuprolide acetate 7.5mg powder for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Leuprolide acetate 30mg powder for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Leuprolide acetate 11.25mg powder for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Leuprolide acetate 22.5mg powder for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Olanzapine 300mg powder for injection suspension Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Olanzapine 210mg powder for injection suspension Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Olanzapine 405mg powder for injection suspension Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Leuprolide acetate 45mg powder for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely paclitaxel 100 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely galactose 3.99 gram and palmitic acid 4 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 12.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 50 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 2.4 million unit/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 7.5 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Accord Healthcare Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Accord Healthcare Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials (Accord Healthcare Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials (Accord Healthcare Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Dr Reddy's Laboratories (UK) Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Tillomed Laboratories Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Tillomed Laboratories Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Sandoz Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Sandoz Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Seacross Pharmaceuticals Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Seacross Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Zentiva Pharma UK Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Zentiva Pharma UK Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Viatris UK Healthcare Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Viatris UK Healthcare Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Benzathine benzylpenicillin 2.4million unit powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg powder for injection solution + diluent Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Leuprolide acetate 11.25mg injection powder for injection solution + diluent Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Triptorelin 4.2mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Rabies inactivated vaccine powder and solvent for injection solution vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Yellow fever live vaccine injection solution vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Galactose microparticles 3996mg/palmitic acid 4mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Triptorelin 3.75mg powder and solvent for injection prefilled syringe Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Triptorelin 15mg powder and dilutent for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Risperidone 37.5mg powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Risperidone 50mg powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Risperidone 25mg powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Diphtheria (adsorbed) / Tetanus / Pertussis (acellular) vaccine injection pre-filled syringes and Haemophilus type b conjugate vaccine injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Meningococcal C conjugate vaccine powder and solvent for suspension for injection 0.5ml vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Varicella vaccine (live) powder and solvent for suspension for injection 0.5ml vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
BCG vaccine powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Benzathine benzylpenicillin 600,000unit powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Benzathine benzylpenicillin 1.2million unit powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Spectinomycin 2g powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Spectinomycin 2g powder and solvent for suspension for injection vials 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Trobicin 2g powder and solvent for suspension for injection vials (Pharmacia Ltd) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Trobicin 2g powder and solvent for suspension for injection vials (Pharmacia Ltd) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Procaine benzylpenicillin 1.2million unit powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Procaine benzylpenicillin 1.2million unit powder and solvent for suspension for injection vials 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Farmaproina 1.2million unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Farmaproina 1.2million unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Procaine benzylpenicillin 600,000unit powder and solvent for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Procaine benzylpenicillin 600,000unit powder and solvent for suspension for injection vials 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Farmaproina 600,000unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Farmaproina 600,000unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Risperdal Consta 37.5mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Risperdal Consta 50mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Risperdal Consta 37.5mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Risperdal Consta 50mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start